[Skip to Content]
[Skip to Content Landing]
Views 590
Citations 0
Clinical Trials Update
March NaN, 2015

Neuroprotective Agent Given Soon After Stroke Shows No Benefit

JAMA. 2015;313(12):1200. doi:10.1001/jama.2015.2211

Although more than 70 neuroprotective agents have failed to show unequivocal benefit in patients with acute ischemic stroke, none of those tested to date were delivered in the hyperacute phase of stroke. However, according to results from the recent Field Administration of Stroke Therapy–Magnesium (FAST-MAG) phase 3 clinical trial, administration of magnesium sulfate to patients with suspected stroke within 2 hours of symptom onset similarly failed to improve functional outcomes (Saver JL et al. N Engl J Med. 2015;372[6]:528-536).

First Page Preview View Large
First page PDF preview
First page PDF preview